OpenLB
Open Library of Bioscience
Advanced Search

Journal

Publication Year

1 year 3 years 5 years 10 years
2021 - 2032
202120222023
202420252026
202720282029
203020312032
2021 - 2032
202120222023
202420252026
202720282029
203020312032

Publication Type

Associated Data

Found 8,501 results

Filters: Antibody-drug conjugate

Antitumor activity of doxorubicin-monoclonal antibody conjugate on human bladder cancer.
D S Yu, T M Chu, M Y Yeh, S Y Chang, C P Ma, S H Han
J Urol. Aug, 1988.140(2):415-21 Print
Source:PubMed
PMID: 3398165 doi:10.1016/s0022-5347(17)41648-x
A novel method of conjugation of daunomycin with antibody with a poly-L-glutamic acid derivative as intermediate drug carrier. An anti-alpha-fetoprotein antibody-daunomycin conjugate.
Y Kato, N Umemoto, Y Kayama, H Fukushima, Y Takeda, T Hara, Y Tsukada
J Med Chem. Dec, 1984.27(12):1602-7 Print
Source:PubMed
PMID: 6209394 doi:10.1021/jm00378a013
Preparation and properties of a drug-carrier-antibody conjugate showing selective antibody-directed cytotoxicity in vitro.
M C Garnett, M J Embleton, E Jacobs, R W Baldwin
Int J Cancer. May 15, 1983.31(5):661-70 Print
Source:PubMed
PMID: 6852982 doi:10.1002/ijc.2910310520
Effects of drug loading on the antitumor activity of a monoclonal antibody drug conjugate.
Kevin J Hamblett, Peter D Senter, Dana F Chace, Michael M C Sun, Joel Lenox, Charles G Cerveny, Kim M Kissler, Starr X Bernhardt, Anastasia K Kopcha, Roger F Zabinski, Damon L Meyer, Joseph A Francisco
Clin Cancer Res. Oct 15, 2004.10(20):7063-70 Print
Source:PubMed
PMID: 15501986 doi:10.1158/1078-0432.CCR-04-0789
Antibody-drug Conjugate Targets, Drugs, and Linkers.
Beverly A Teicher, Joel Morris
Curr Cancer Drug Targets. 2022.22(6):463-529 Print
Source:PubMed
PMID: 35209819 doi:10.2174/1568009622666220224110538
[Determination of drug antibody ratio in an antibody-drug conjugate].
Chuan-Fei Yu, Meng Li, Wei Guo, Lan Wang, Feng Zhang, Chun-Yu Liu, Wen-Bo Wang, Jun-Zhi Wang, Kai Gao
Yao Xue Xue Bao. Mar, 2014.49(3):363-7 Print
Source:PubMed
PMID: 24961108 doi:
[Cytotoxic effect of anticancer drug combined with anti-AFP antibody on human hepatoma cell in vitro].
K Kukita
Hokkaido Igaku Zasshi. May, 1990.65(3):254-65 Print
Source:PubMed
PMID: 1696238 doi:
Antibody-drug conjugates: using monoclonal antibodies for delivery of cytotoxic payloads to cancer cells.
Victor S Goldmacher, Yelena V Kovtun
Ther Deliv. Mar, 2011.2(3):397-416 Print
Source:PubMed
PMID: 22834009 doi:10.4155/tde.10.98
Development of a generalized pharmacokinetic model to characterize clinical pharmacokinetics of monomethyl auristatin E-based antibody-drug conjugates.
Hsuan-Ping Chang, Yuen Kiu Cheung, Shufang Liu, Dhaval K Shah
Br J Clin Pharmacol. Jul, 2024.90(7):1637-1655 Print-Electronic
Source:PubMed
PMID: 38566392 doi:10.1111/bcp.16057
Biodistribution and tumour localisation of a daunomycin-monoclonal antibody conjugate in nude mice with human tumour xenografts.
M V Pimm, M A Paul, Y Ogumuyiwa, R W Baldwin
Cancer Immunol Immunother. 1988.27(3):267-71 Print
Source:PubMed
PMID: 3180150 doi:10.1007/BF00205450
0